Michael Henry Fiore Sells 1,794 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction that occurred on Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares of the company's stock, valued at $5,414,579.25. This represents a 3.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

HealthEquity Price Performance

NASDAQ HQY traded up $1.29 on Tuesday, reaching $103.12. 972,980 shares of the company's stock traded hands, compared to its average volume of 863,458. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $116.65. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. The stock has a 50-day simple moving average of $100.09 and a 200 day simple moving average of $98.36. The stock has a market cap of $8.92 billion, a PE ratio of 75.27, a P/E/G ratio of 1.57 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The business had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. During the same period last year, the business earned $0.80 earnings per share. As a group, research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analyst Weigh In

HQY has been the subject of a number of recent analyst reports. JMP Securities increased their target price on shares of HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. Wall Street Zen raised shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Bank of America increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. The Goldman Sachs Group increased their target price on shares of HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a research report on Wednesday, June 4th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $118.55.

Institutional Trading of HealthEquity

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Wealthfront Advisers LLC purchased a new position in HealthEquity during the fourth quarter valued at $10,304,089,000. Invesco Ltd. lifted its position in HealthEquity by 50.6% during the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company's stock valued at $216,171,000 after buying an additional 821,425 shares during the period. T. Rowe Price Investment Management Inc. purchased a new position in HealthEquity during the fourth quarter valued at $78,107,000. Norges Bank purchased a new position in HealthEquity during the fourth quarter valued at $74,701,000. Finally, Nuveen LLC purchased a new position in HealthEquity during the first quarter valued at $53,076,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.